{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:06:01Z","timestamp":1789297561748,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Peking University Medicine Sailing Program for Young Scholars\u2019 Scientific & Technological Innovation\uff1bthe Fundamental Research Funds for the Central Universities","award":["BMU2023YFJHPY007"],"award-info":[{"award-number":["BMU2023YFJHPY007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273389"],"award-info":[{"award-number":["82273389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473287"],"award-info":[{"award-number":["82473287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Key Project of Peking University Third Hospital","award":["BYSYZD2025002"],"award-info":[{"award-number":["BYSYZD2025002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20557-9","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:29:29Z","timestamp":1789237769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytoreductive Nephrectomy and Thrombectomy for Metastatic Renal Cell Carcinoma with Venous Tumor Thrombus: Experience from a High-Volume Center"],"prefix":"10.1245","author":[{"given":"Peichen","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-8872","authenticated-orcid":false,"given":"Peng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"5","key":"20557_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1464-410X.2010.09593.x","volume":"107","author":"JM Whitson","year":"2011","unstructured":"Whitson JM, Reese AC, Meng MV. Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus. BJU Int. 2011;107(5):729\u201334.","journal-title":"BJU Int."},{"issue":"4","key":"20557_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.urolonc.2022.11.021","volume":"41","author":"AL Almatari","year":"2023","unstructured":"Almatari AL, Sathe A, Wideman L, et al. Renal cell carcinoma with tumor thrombus: A review of relevant anatomy and surgical techniques for the general urologist. Urol Oncol. 2023;41(4):153\u201365.","journal-title":"Urol Oncol."},{"issue":"1","key":"20557_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12885-026-15622-1","volume":"26","author":"C He","year":"2026","unstructured":"He C, Zhang R, Zhang H, et al. Influence of the azygos venous pathway state on the surgical complexity of patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective, large-sample study from China. BMC Cancer. 2026;26(1):430.","journal-title":"BMC Cancer."},{"issue":"10","key":"20557_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/jocs.14182","volume":"34","author":"G Serena","year":"2019","unstructured":"Serena G, Gonzalez J, Gaynor JJ, et al. Pulmonary tumor embolization as early manifestation in patients with renal cell carcinoma and tumor thrombus: Perioperative management and outcomes. J Card Surg. 2019;34(10):1018\u201323.","journal-title":"J Card Surg."},{"issue":"4","key":"20557_CR5","first-page":"e58113","volume":"16","author":"SA Bernaschina-Rivera","year":"2024","unstructured":"Bernaschina-Rivera SA, Alayon-Rosario G, Dieppa-Barnes G, et al. Renal cell carcinoma with tumor thrombus: a case series in Puerto Rico. Cureus. 2024;16(4):e58113.","journal-title":"Cureus."},{"issue":"11","key":"20557_CR6","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1111\/jocs.16874","volume":"37","author":"K Chen","year":"2022","unstructured":"Chen K, Liu Z, Li Y, et al. Diagnosis and treatment strategies for intraoperative pulmonary embolism caused by renal tumor thrombus shedding. J Card Surg. 2022;37(11):3973\u201383.","journal-title":"J Card Surg."},{"issue":"2","key":"20557_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.juro.2013.02.033","volume":"190","author":"EJ Abel","year":"2013","unstructured":"Abel EJ, Wood CG, Eickstaedt N, et al. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol. 2013;190(2):452\u20137.","journal-title":"J Urol."},{"issue":"8","key":"20557_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","volume":"35","author":"T Powles","year":"2024","unstructured":"Powles T, Albiges L, Bex A, et al. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(8):692\u2013706.","journal-title":"Ann Oncol."},{"issue":"6","key":"20557_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, et al. European Association of Urology guidelines on renal cell carcinoma: the 2025 update. Eur Urol. 2025;87(6):683\u201396.","journal-title":"Eur Urol."},{"issue":"1","key":"20557_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11934-025-01301-4","volume":"26","author":"M Sandberg","year":"2025","unstructured":"Sandberg M, Bissette JR, Waggener K, et al. Reviewing the current state of renal cell carcinoma with a tumor thrombus: epidemiology, pathophysiology, metastasis, and systemic therapy. Curr Urol Rep. 2025;26(1):71.","journal-title":"Curr Urol Rep."},{"issue":"3","key":"20557_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10147-017-1232-9","volume":"23","author":"H Miyake","year":"2018","unstructured":"Miyake H, Sugiyama T, Aki R, et al. Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus. Int J Clin Oncol. 2018;23(3):553\u20138.","journal-title":"Int J Clin Oncol."},{"issue":"10","key":"20557_CR12","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s41416-023-02166-5","volume":"128","author":"A Mittal","year":"2023","unstructured":"Mittal A, Al-Ezzi E, Li X, et al. The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma. Br J Cancer. 2023;128(10):1888\u201396.","journal-title":"Br J Cancer."},{"issue":"1","key":"20557_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1464-410X.2004.04897.x","volume":"94","author":"ML Blute","year":"2004","unstructured":"Blute ML, Leibovich BC, Lohse CM, et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94(1):33\u201341.","journal-title":"BJU Int."},{"issue":"4","key":"20557_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.juro.2013.04.025","volume":"190","author":"PD Yoon","year":"2013","unstructured":"Yoon PD, Chalasani V, Woo H. Use of Clavien-Dindo classification in reporting and grading complications after urological surgical procedures: analysis of 2010 to 2012. J Urol. 2013;190(4):1271\u20134.","journal-title":"J Urol."},{"issue":"7","key":"20557_CR15","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/PAS.0000000000002233","volume":"48","author":"AJ Adeniran","year":"2024","unstructured":"Adeniran AJ, Shuch B, Humphrey PA. Sarcomatoid and rhabdoid renal cell carcinoma: clinical, pathologic, and molecular genetic features. Am J Surg Pathol. 2024;48(7):e65\u201388.","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"20557_CR16","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1002\/mco2.300","volume":"4","author":"L Qu","year":"2023","unstructured":"Qu L, Chen H, Chen Q, Ge S, Jiang A, Yu N, Zhou Y, Kunc M, Zhou Y, Feng X, Zhai W. Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study. MedComm. 2023;4(4):e300.","journal-title":"MedComm."},{"issue":"1","key":"20557_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12894-020-0584-z","volume":"20","author":"B Yang","year":"2020","unstructured":"Yang B, Xia H, Xu C, et al. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically. BMC Urol. 2020;20(1):14.","journal-title":"BMC Urol."},{"key":"20557_CR18","doi-asserted-by":"publisher","first-page":"e2500376","DOI":"10.1200\/GO-25-00376","volume":"11","author":"F Massari","year":"2025","unstructured":"Massari F, Rosellini M, Melichar B, et al. Sarcomatoid differentiation in renal cell carcinoma: clinical and pathologic heterogeneity and outcomes with immune checkpoint inhibitors-data from the ARON-1 Study. JCO Glob Oncol. 2025;11:e2500376.","journal-title":"JCO Glob Oncol."},{"issue":"2","key":"20557_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.juro.2017.03.011","volume":"198","author":"EJ Abel","year":"2017","unstructured":"Abel EJ, Spiess PE, Margulis V, et al. Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus. J Urol. 2017;198(2):281\u20138.","journal-title":"J Urol."},{"issue":"1","key":"20557_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12957-023-03048-z","volume":"21","author":"K Chen","year":"2023","unstructured":"Chen K, Liu Z, Li Y, et al. Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center. World J Surg Oncol. 2023;21(1):170.","journal-title":"World J Surg Oncol."},{"issue":"5","key":"20557_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.euf.2025.05.023","volume":"11","author":"QC Le","year":"2025","unstructured":"Le QC, Marmiroli A, Longoni M, et al. Life expectancy of renal cell carcinoma with variant histology. Eur Urol Focus. 2025;11(5):810\u201320.","journal-title":"Eur Urol Focus."},{"issue":"13","key":"20557_CR22","doi-asserted-by":"publisher","first-page":"14149","DOI":"10.1002\/cam4.6081","volume":"12","author":"K Wang","year":"2023","unstructured":"Wang K, Duan P, Chen X, et al. Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations. Cancer Med. 2023;12(13):14149\u201356.","journal-title":"Cancer Med."},{"issue":"4","key":"20557_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.eururo.2021.06.009","volume":"80","author":"A M\u00e9jean","year":"2021","unstructured":"M\u00e9jean A, Ravaud A, Thezenas S, et al. Sunitinib alone or after nephrectomy for patients with metastatic renal cell carcinoma: is there still a role for cytoreductive nephrectomy? Eur Urol. 2021;80(4):417\u201324.","journal-title":"Eur Urol."},{"issue":"1","key":"20557_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bju.15625","volume":"130","author":"Y Abu-Ghanem","year":"2022","unstructured":"Abu-Ghanem Y, van Thienen JV, Blank C, et al. Cytoreductive nephrectomy and exposure to sunitinib-a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial. BJU Int. 2022;130(1):68\u201375.","journal-title":"BJU Int."},{"issue":"10","key":"20557_CR25","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1007\/s00464-024-11041-0","volume":"38","author":"K Chen","year":"2024","unstructured":"Chen K, Yu L, Ge L, et al. A nomogram predicting intraoperative adverse events during minimally invasive radical nephrectomy and thrombectomy. Surg Endosc. 2024;38(10):5891\u2013902.","journal-title":"Surg Endosc."},{"issue":"6","key":"20557_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euo.2018.10.005","volume":"2","author":"Y Freifeld","year":"2019","unstructured":"Freifeld Y, Woldu SL, Singla N, et al. Impact of hospital case volume on outcomes following radical nephrectomy and inferior vena cava thrombectomy. Eur Urol Oncol. 2019;2(6):691\u20138.","journal-title":"Eur Urol Oncol."},{"issue":"1","key":"20557_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1245\/s10434-025-18345-y","volume":"33","author":"L Yu","year":"2026","unstructured":"Yu L, Zhang W, Duan P, et al. Segmental resection of the inferior vena cava is safe and feasible for patients with renal cell carcinoma with tumor thrombus: a large-scale retrospective study from a high-volume center. Ann Surg Oncol. 2026;33(1):824\u201331.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"20557_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/CU9.0000000000000265","volume":"19","author":"J Luo","year":"2025","unstructured":"Luo J, Li Z, Liu Q, et al. Robotic surgical techniques and methods for treating renal cell carcinoma with inferior vena cava tumor thrombus. Curr Urol. 2025;19(3):177\u201386.","journal-title":"Curr Urol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20557-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20557-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:01:39Z","timestamp":1789297299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20557-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":28,"alternative-id":["20557"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20557-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All patients provided written informed consent, and the study protocol was approved by the institutional committee on human research. This study was reviewed and approved by the Peking University Third Hospital Medical Science research ethics committee (M20250639). The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}